a developer of RNAi-based medical technologies and therapies
Industry Biotechnology
A.I.dvisor indicates that over the last year, PHIO has been closely correlated with RIGL. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if PHIO jumps, then RIGL could also see price increases.
Ticker / NAME | Correlation To PHIO | 1D Price Change % | ||
---|---|---|---|---|
PHIO | 100% | -8.20% | ||
RIGL - PHIO | 84% Closely correlated | +0.70% | ||
CLNN - PHIO | 83% Closely correlated | -9.06% | ||
HOOK - PHIO | 81% Closely correlated | -4.74% | ||
DARE - PHIO | 81% Closely correlated | -13.04% | ||
AZTR - PHIO | 74% Closely correlated | -3.87% | ||
More |
Ticker / NAME | Correlation To PHIO | 1D Price Change % |
---|---|---|
PHIO | 100% | -8.20% |
PHIO (8 stocks) | 18% Poorly correlated | -4.04% |
biotechnology (238 stocks) | 5% Poorly correlated | -1.80% |
therapy (23 stocks) | 4% Poorly correlated | -3.41% |
drugs (254 stocks) | 4% Poorly correlated | -1.72% |